The previous announcment regarding clinical trials in November 2022 came in with 2 contracts at a combined total of $1.5m AU. One would expect and therefore hope this announcement will be of much higher value and significance given the trading halt.
In the most recent quarterly there was talk about making progress with a large opportunity in Australia, might this be it? Any speculation of who this could be with?
Ann: Trading Halt, page-10
-
- There are more pages in this discussion • 43 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
